Managing side effects starts with starting low and going slowexactly how PlexusDx structures its dosing protocol
In the SURMOUNT-1 trial, the highest dose produced average weight loss of 22.5% over 72 weeks
During this phase, the body composition changes become increasingly dramatic
Individuals who are pregnant, planning on becoming pregnant, breastfeeding, have a history of severe kidney or liver disease, pancreatitis, gallbladder disease, diabetic retinopathy, thyroid C-cell tumors, certain types of cancer, or those who have had severe hypersensitivity to Semaglutide or any of its components may not be suitable for this treatment
Low-dose spironolactone and cardiovascular outcomes in moderate stage chronic kidney disease: a randomized controlled trial